Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Springer Science and Business Media LLC - 2019
Junko Yano1, Jack D. Sobel2, Paul Nyirjesy3, Ryan Sobel4, Valerie L. Williams5, Qingzhao Yu6, Mairi C. Noverr7, Paul L. Fidel1
1Center of Excellence in Oral and Craniofacial Biology, School of Dentistry, Louisiana State University Health Sciences Center, New Orleans, LA, USA
2Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI USA
3Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, PA, USA
4Thomas Jefferson University Hospital, Sydney Kimmel Medical College, Philadelphia, PA, USA
5Department of Obstetrics and Gynecology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA
6Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA
7Present Address: Department of Microbiology and Immunology, School of Medicine, Tulane University, 1430 Tulane Ave, New Orleans, LA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152(7 Pt 2):924–35.

Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178(2):203–11.

Fidel PL Jr, Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun. 2004;72:2939–46.

Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 1992;14(Suppl 1):S148–53.

Sobel JD. Vaginitis. N Engl J Med. 1997;337(26):1896–903.

Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253–73.

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339–e47.

Blostein F, Levin-Sparenberg E, Wagner J, Foxman B. Recurrent vulvovaginal candidiasis. Ann Epidemiol. 2017;27(9):575–82.

Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–71.

Fidel PL Jr. History and new insights into host defense against vaginal candidiasis. Trends Microbiol. 2004;12(5):220–7.

Peters BM, Yano J, Noverr MC, Fidel PL Jr. Candida vaginitis: when opportunism knocks, the host responds. PLoS Pathog. 2014;10(4):e1003965.

Yano J, Noverr MC, Fidel PL Jr. Cytokines in the host response to Candida vaginitis: identifying a role for non-classical immune mediators, S100 alarmins. Cytokine. 2012;58(1):118–28.

Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG. 2015;122(6):785–94.

Yano J, Noverr MC, Fidel PL Jr. Vaginal heparan sulfate linked to neutrophil dysfunction in the acute inflammatory response associated with experimental vulvovaginal candidiasis. mBio. 2017;8(2):e00211–7.

Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J. 1979;55(647):645–7.

Geiger AM, Foxman B, Gillespie BW. The epidemiology of vulvovaginal candidiasis among university students. Am J Public Health. 1995;85(8 Pt 1):1146–8.

Berg AO, Heidrich FE, Fihn SD, Bergman JJ, Wood RW, Stamm WE, et al. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA. 1984;251(5):620–5.

Horowitz BJ, Edelstein SW, Lippman L. Sexual transmission of Candida. Obstet Gynecol. 1987;69(6):883–6.

Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291(11):1368–79.

Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J Women's Health. 1998;7(9):1167–74.

Fischer G, Bradford J. Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy. J Low Genit Tract Dis. 2011;15(4):263–7.

Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol. 2001;185(2):363–9.

Reef SE, Levine WC, McNeil MM, Fisher-Hoch S, Holmberg SD, Duerr A, et al. Treatment options for vulvovaginal candidiasis, 1993. Clin Infect Dis. 1995;20(Suppl 1):S80–90.

Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876–83.

Farmer MA, Taylor AM, Bailey AL, Tuttle AH, MacIntyre LC, Milagrosa ZE, et al. Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med. 2011;3(101):101ra91.

Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340–5.

Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology. 1996;7(2):182–7.

de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.

Drell T, Lillsaar T, Tummeleht L, Simm J, Aaspollu A, Vain E, et al. Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women. PLoS One. 2013;8(1):e54379.

Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27(4):230–5.

Geiger AM, Foxman B, Sobel JD. Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida. Genitourin Med. 1995;71(5):304–7.

Mintz JD, Martens MG. Prevalence of non-albicans Candida infections in women with recurrent vulvovaginal symptomatology. Adv Infect Dis. 2013;3(4):5.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả